According to a new market report published by Lucintel, the future of the blood transfusion diagnostic market looks promising with opportunities in blood grouping and disease screening. The global blood transfusion diagnostic market is expected to grow with a CAGR of 7% from 2020 to 2025. The major drivers for this market are rising prevalence of chronic diseases and increasing demand for donor screening.
To download report brochure, please go to https://www.lucintel.com/blood-transfusion-diagnostic-market.aspx and click "download brochure" tab from the menu
Blood transfusion is the process of transferring blood from one person into bloodstream of another person. In this market, reagents & kits and instruments are the major product types. Lucintel forecasts that reagents & kits will remain the largest product segment over the forecast period due to repetitive purchase of these products and the availability of a wide variety of blood grouping, typing, and donor screening reagents, kits, and assays.
Within this market, blood banks will remain the largest end use segment over the forecast period due to a surge in disease screening and blood typing services.
North America will remain the largest region over the forecast period due to the presence of major companies, easy availability of various assays, and growing awareness among people of blood donations.
Grifols, Immucor, Ortho Clinical Diagnostic, Abbott Laboratories, Bio-Rad Laboratories, F. Hoffmann-La Roche, and Quotient are among the major suppliers in the global blood transfusion diagnostic market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global blood transfusion diagnostic market by product, application, end use, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Blood Transfusion Diagnostic Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global blood transfusion diagnostic market by product, application, end use, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Reagents & Kits
Instruments
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Blood Grouping
Disease Screening
By End Use [Value ($ Million) shipment analysis for 2014 – 2025]:
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Spain
Germany
France
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.